Safety of Onartuzumab in Patients with Solid Tumors: Experience to Date from the Onartuzumab Clinical Trial Program.
PLoS One
; 10(10): e0139679, 2015.
Article
in En
| MEDLINE
| ID: mdl-26445503
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Thromboembolism
/
Hypoalbuminemia
/
Edema
/
Venous Thromboembolism
/
Intestinal Perforation
/
Antibodies, Monoclonal
Type of study:
Clinical_trials
/
Guideline
Limits:
Humans
Language:
En
Journal:
PLoS One
Journal subject:
CIENCIA
/
MEDICINA
Year:
2015
Document type:
Article
Affiliation country: